FMRP facilitates colorectal cancer progression by stabilizing the mRNA of EGFR, a process that relies on m6A modification, suggesting that targeted intervention at specific m6A sites could serve as a therapeutic strategy.204. The gene discussed is EGFR; the disease is colorectal cancer.